These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis]. Erov NK Ter Arkh; 1986; 58(7):73-7. PubMed ID: 2945279 [TBL] [Abstract][Full Text] [Related]
5. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man. Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441 [No Abstract] [Full Text] [Related]
6. [Effect of the enzyme preparation longolytin on fibrinolysis in animals]. Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406 [TBL] [Abstract][Full Text] [Related]
7. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen. Johnson AJ; Tse A; Skoza L Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648 [No Abstract] [Full Text] [Related]
8. The primary plasmin inhibitor in rheumatoid synovial fluid. Clemmensen I; Donde R; Andersen RB Arthritis Rheum; 1977; 20(7):1354-8. PubMed ID: 143941 [TBL] [Abstract][Full Text] [Related]
9. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
10. [The structure of immunoglobulins and the problem of associated proteases]. Robert B Prog Immunobiol Stand; 1970; 4():13-6. PubMed ID: 4099024 [No Abstract] [Full Text] [Related]
11. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies]. Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611 [No Abstract] [Full Text] [Related]
12. [Inflammation and enzymes]. Fujii S Nihon Ishikai Zasshi; 1971 Apr; 65(7):862-78. PubMed ID: 4252047 [No Abstract] [Full Text] [Related]
13. The extra-articular deposition of fibrinogen antigenic material in patients with rheumatoid arthritis. Danneskiold-Samsøe B; Clemmensen I; Andersen RB Scand J Rheumatol; 1979; 8(2):87-90. PubMed ID: 88067 [TBL] [Abstract][Full Text] [Related]
14. The immunochemical demonstration of leucocyte proteases and inhibitors using fibrinagarelectrophoresis. Hermann G Prog Immunobiol Stand; 1970; 4():422-5. PubMed ID: 4249359 [No Abstract] [Full Text] [Related]
15. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo. Nanninga LB Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474 [TBL] [Abstract][Full Text] [Related]
17. [Value of determining complex heparin compounds for early diagnosis and evaluation of the degree of severity of late pregnancy toxemia]. Zakharova TP Akush Ginekol (Mosk); 1986 Apr; (4):57-9. PubMed ID: 2940925 [No Abstract] [Full Text] [Related]